Immunic, Inc. (IMUX)
6.99
+0.02
(+0.29%)
USD |
NASDAQ |
Oct 19, 13:55
Immunic Cash from Operations (Annual) : -85.81M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -85.81M |
| December 31, 2024 | -84.77M |
| December 31, 2023 | -70.83M |
| December 31, 2022 | -65.14M |
| December 31, 2021 | -83.23M |
| December 31, 2020 | -46.12M |
| December 31, 2019 | -28.82M |
| December 31, 2018 | -9.738M |
| Date | Value |
|---|---|
| December 31, 2017 | -40.40M |
| December 31, 2016 | -35.77M |
| December 31, 2015 | -49.95M |
| December 31, 2014 | -40.82M |
| December 31, 2013 | -28.65M |
| December 31, 2012 | -9.244M |
| December 31, 2011 | -7.831M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Sionna Therapeutics, Inc. | -66.30M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |